Type 2 Diabetes Trial, Recruiting NCT05325710 Sponsor: GCS Ramsay Santé pour l'Enseignement et la Recherche Condition: Type 2 Diabetes
Back to Type 2 Diabetes

Type 2 Diabetes Trial, Recruiting

NCT05325710
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • Adults aged 18 or older (but not older than 75)
  • People who have scored 10 points or more on the FINDRISC questionnaire, which is a tool used to assess the risk of developing type 2 diabetes
  • People who are covered by the French health insurance system
  • People who have been fully informed about the trial and have signed a written consent form agreeing to take part

Who may not be able to join:

  • People over the age of 75
  • People who have already been diagnosed with type 2 diabetes
  • People whose physical or mental health is severely affected in a way that the trial doctor believes could make it difficult to follow the study requirements
  • People who are currently taking part in another research study
  • People who are still within an exclusion period from a previous research study at the time of joining
  • People who are under legal protection measures, such as guardianship or curatorship, or who have had their freedom restricted by a court or government authority
  • Women who are pregnant, breastfeeding, or in labour
  • People who are hospitalised and have not given their consent to participate

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 15 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 068346567

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
GCS Ramsay Santé pour l'Enseignement et la Recherche
Registry
ClinicalTrials.gov
Start date
20 March 2022
Est. completion
1 April 2028

Where this trial is recruiting

🇫🇷 France

Primary endpoints

FINDRISC score

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 15 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov